AI Clinical Trial Compliance Specialist
An AI Clinical Trial Compliance Specialist ensures that artificial intelligence and machine learning systems deployed in pharmaceu…
Skill Guide
The systematic process of evaluating AI/ML models intended for clinical applications for potential failures, biases, and unintended consequences that could impact patient safety, efficacy, or regulatory approval for defined medical outcomes.
Scenario
You are given a pre-trained model (e.g., from Papers with Code) for diabetic retinopathy grading and a dataset with demographic metadata. Your task is to assess its risk for a prospective clinical trial.
Scenario
A startup's AI model claims to detect low ejection fraction from a standard 12-lead ECG. As a risk consultant, you must prepare the risk assessment section for a 510(k) submission to the FDA.
Scenario
Your company's AI model is live in hospitals, recommending therapy based on tumor genomics. A new cancer treatment is approved, potentially creating a data shift that degrades model performance. You must design the post-market surveillance protocol.
These provide the mandatory checklist and governance structure for clinical AI risk. ISO 14971 is the gold standard for risk management in medical devices, requiring a risk management file with traceable risk controls.
Aequitas provides a CLI for auditing model fairness across specified attributes. Alibi Detect is used in production to detect dataset and concept drift that could compromise endpoint validity. Explainability tools are non-negotiable for justifying model decisions to clinicians and regulators.
Answer Strategy
Structure your answer using a risk taxonomy: Performance Risk (calibration on subgroup endpoints), Data/Provenance Risk (leakage from prior visits), Operational Risk (input errors in EHR), and Fairness Risk (disparity by insurance status). Quantify using metrics like Net Benefit for clinical utility, and disparity ratios for fairness. State that the final risk score is a composite of likelihood and severity of harm to the readmission-reduction endpoint.
Answer Strategy
Test understanding of process discipline under pressure. The answer must prioritize safety and traceability over speed. Strategy: 1) Immediately initiate a root cause analysis (data drift? new scanner hardware?). 2) Escalate per predefined protocol; clinical operations may need to be notified. 3) Any fix must go through full re-validation on a hold-out dataset that includes the degrading segment. 4) The decision to deploy requires a formal risk-benefit sign-off from the clinical and regulatory stakeholders, not just engineering.
1 career found
Try a different search term.